CURRENT Medical Diagnosis and
Treatment 2026
65th Edition
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANK
1
Reference
Ch. 1 — Disease Prevention & Health Promotion — Preventive
Services & Screening. yumpu.com+1
Question Stem
A 58-year-old man with hypertension and a 30-pack-year
,smoking history asks which screening test will most reduce his
lung-cancer mortality risk. Which is the best recommendation?
A. Annual chest radiograph starting now.
B. Low-dose CT (LDCT) annually for current smokers aged 50–80
with ≥20 pack-years.
C. Sputum cytology annually.
D. No screening — recommend smoking cessation only.
Correct Answer
B
Rationales
• B (Correct): CMDT recommends annual low-dose CT for
appropriate high-risk smokers because LDCT reduces lung-
cancer mortality compared with chest radiograph or no
screening. This patient meets age and smoking-risk
thresholds. yumpu.com
• A: Chest radiographs do not reduce lung-cancer mortality
and are not recommended for screening. yumpu.com
• C: Sputum cytology lacks sensitivity and evidence for
mortality benefit compared with LDCT. yumpu.com
• D: Smoking cessation is essential, but for someone
meeting LDCT criteria, screening plus cessation is
recommended rather than omission of screening.
yumpu.com
,Teaching Point
Annual LDCT for eligible high-risk smokers reduces lung-cancer
mortality.
Citation (Simplified APA)
Papadakis et al. (2026). CURRENT Medical Diagnosis &
Treatment 2026 (65th Ed.). Ch. 1.
2
Reference
Ch. 1 — Disease Prevention & Health Promotion — Adult
Immunizations & Counseling.
accessmedicine.mhmedical.com+1
Question Stem
A 67-year-old woman with well-controlled diabetes asks about
pneumococcal vaccination. Which plan best matches CMDT
recommendations?
A. Single dose PPSV23 only at age ≥65.
B. PCV20 (or shared decision pathway) or sequential PCV15
then PPSV23 as per age and risk.
C. No pneumococcal vaccine is indicated for well-controlled
diabetes.
D. Annual PPSV23 booster.
Correct Answer
B
, Rationales
• B (Correct): CMDT summarizes current adult
pneumococcal guidance: newer conjugate vaccines (PCV20
or PCV15→PPSV23 sequence) are recommended for older
adults and those with diabetes per shared decision
frameworks. accessmedicine.mhmedical.com
• A: PPSV23 alone is no longer the only option; conjugate
vaccines offer broader, longer-lasting protection in eligible
adults. accessmedicine.mhmedical.com
• C: Diabetes increases pneumococcal disease risk;
vaccination is recommended.
accessmedicine.mhmedical.com
• D: Routine annual PPSV23 boosters are not recommended;
boosters are given selectively.
accessmedicine.mhmedical.com
Teaching Point
Use PCV20 or PCV15→PPSV23 per age/risk for older adults and
those with diabetes.
Citation (Simplified APA)
Papadakis et al. (2026). CURRENT Medical Diagnosis &
Treatment 2026 (65th Ed.). Ch. 1.
3
Treatment 2026
65th Edition
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANK
1
Reference
Ch. 1 — Disease Prevention & Health Promotion — Preventive
Services & Screening. yumpu.com+1
Question Stem
A 58-year-old man with hypertension and a 30-pack-year
,smoking history asks which screening test will most reduce his
lung-cancer mortality risk. Which is the best recommendation?
A. Annual chest radiograph starting now.
B. Low-dose CT (LDCT) annually for current smokers aged 50–80
with ≥20 pack-years.
C. Sputum cytology annually.
D. No screening — recommend smoking cessation only.
Correct Answer
B
Rationales
• B (Correct): CMDT recommends annual low-dose CT for
appropriate high-risk smokers because LDCT reduces lung-
cancer mortality compared with chest radiograph or no
screening. This patient meets age and smoking-risk
thresholds. yumpu.com
• A: Chest radiographs do not reduce lung-cancer mortality
and are not recommended for screening. yumpu.com
• C: Sputum cytology lacks sensitivity and evidence for
mortality benefit compared with LDCT. yumpu.com
• D: Smoking cessation is essential, but for someone
meeting LDCT criteria, screening plus cessation is
recommended rather than omission of screening.
yumpu.com
,Teaching Point
Annual LDCT for eligible high-risk smokers reduces lung-cancer
mortality.
Citation (Simplified APA)
Papadakis et al. (2026). CURRENT Medical Diagnosis &
Treatment 2026 (65th Ed.). Ch. 1.
2
Reference
Ch. 1 — Disease Prevention & Health Promotion — Adult
Immunizations & Counseling.
accessmedicine.mhmedical.com+1
Question Stem
A 67-year-old woman with well-controlled diabetes asks about
pneumococcal vaccination. Which plan best matches CMDT
recommendations?
A. Single dose PPSV23 only at age ≥65.
B. PCV20 (or shared decision pathway) or sequential PCV15
then PPSV23 as per age and risk.
C. No pneumococcal vaccine is indicated for well-controlled
diabetes.
D. Annual PPSV23 booster.
Correct Answer
B
, Rationales
• B (Correct): CMDT summarizes current adult
pneumococcal guidance: newer conjugate vaccines (PCV20
or PCV15→PPSV23 sequence) are recommended for older
adults and those with diabetes per shared decision
frameworks. accessmedicine.mhmedical.com
• A: PPSV23 alone is no longer the only option; conjugate
vaccines offer broader, longer-lasting protection in eligible
adults. accessmedicine.mhmedical.com
• C: Diabetes increases pneumococcal disease risk;
vaccination is recommended.
accessmedicine.mhmedical.com
• D: Routine annual PPSV23 boosters are not recommended;
boosters are given selectively.
accessmedicine.mhmedical.com
Teaching Point
Use PCV20 or PCV15→PPSV23 per age/risk for older adults and
those with diabetes.
Citation (Simplified APA)
Papadakis et al. (2026). CURRENT Medical Diagnosis &
Treatment 2026 (65th Ed.). Ch. 1.
3
